Page last updated: 2024-10-24

cefixime and Campylobacter Infection

cefixime has been researched along with Campylobacter Infection in 2 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Debelo, M1
Mohammed, N1
Tiruneh, A1
Tolosa, T1
Pascual, A1
Martínez-Martínez, L1
García-Gestoso, ML1
Romero, J1

Other Studies

2 other studies available for cefixime and Campylobacter Infection

ArticleYear
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections

2022
Urinary tract infection caused by quinolone-resistant Campylobacter coli.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:8

    Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Cefixime; Cefotaxime; Female; H

1994